Please assess the completion status of the following clinical trial:

Trial Title: Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Thai menopausal women aged between 50-70 years who visit Rajavithi gynecology OPD with informed consent with good communication in the Thai language.~Exclusion Criteria:~* Have acute vulvovaginitis (vaginal swab for wet smear and KOH)~* Patients who have used hormonal replacement therapy within 12 months~* Patients with a history of smoking~* Patients who have used vaginal lubricant or moisturizer~* Patients with an allergic history of oxytocin or gel components~* Morbid obesity BMI \> 30 kg/m2~* Patients who have used vitamin E supplement~* Patients who unable to perform per vaginal examination

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Oxytocin gel (Type: EXPERIMENTAL): Oxytocin gel 400IU per 1 ml (on HPMC 4,000 cps base gel), applied at vaginal canal 1 ml per day for 8 weeks
- Placebo gel (Type: PLACEBO_COMPARATOR): Placebo gel (HPMC 4,000 cps base gel) , applied at vaginal canal 1 ml per day for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).